Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-30 @ 8:26 AM
Study NCT ID:
NCT00258960
Status:
COMPLETED
Last Update Posted:
2023-04-04
First Post:
2005-11-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GEICAM/2004-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |